The study of drugs: structure, physical properties, chemical characteristics relevant to its activity as therapeuticagent
Pharmacology
The science of substances used to prevent, diagnose and treat diseases
Drug
Substance that brings about change in biologic function through its chemical actions
Drug
Any article used in the Mitigation, Diagnosis, Prevention and Cure of diseases in man and animals
Drug
Defined as "to bind" specific portion of the body
Drug-receptor interaction will not produce an immediate effect, it must first stimulate the production of an effector
Effectors
Translates drug-receptor interaction
Pharmacokinetics
Action of the body (Katawan) on the Drug (Absorption, Distribution, Metabolism, Elimination)
Pharmacokinetics
Fate of the drug inside the body (What will happen to drug)
Liberation
Release of drug from its dosage form for it to be absorbed by the body
Factors affecting liberation
Formulation of salts for easy absorption
Formulation of prodrug
Prodrug
Drugs that are inactive in the native form but active in vivo
Prodrug
Drugs that are inactive in vitro/outside the body, but once taken or administered, they become active
Why we produce prodrugs
To enhance absorption
To facilitate the drug reaching the target site
To alter solubility
Formulation of dosage form
Prodrugs
Enalapril (Ethyl ester of enalaprilat)
Olsalazine (Dimer of mesalamine)
Chloramphenicol palmitate
Absorption
When the drug enters the systemic circulation (from the site of administration to the systemic circulation)
Factors affecting absorption
Chemical structure (NP > Polar)
Variation in particle size & surface area (↓PS and ↑SA)
Nature of crystalline form (amorphous — faster, crystalline — slower absorption)
Type of tablet coating and matrix
Distribution
Drug reaches the target site of action (from systemic circulation to the target site of action)
Factors affecting distribution
Blood flow (↑ in heart, lungs and liver)
Capillary permeability (↑ in liver, ↓ in BBB)
Protein binding
Affinity of drugs to tissue deposits (↑NP)
Protein binding
Warfarin (90% bound to albumin) and phenylbutazone (98% bound to albumin)
Metabolism
2 types: Phase 1 (functionalization or asynthetic) and Phase 2 (conjugation or synthetic)
Phase 1 metabolism
Introduces a polar functional group (-OH, -COOH, -SH, -NH2) to the xenobiotic molecule
Phase 2 metabolism
Attach a small, polar, ionizable endogenous compound to the functional handles of Phase 1
Most drugs under phase 2 metabolism will undergo Glucuronidation Reaction, except for infants or neonates who will undergo sulfation metabolism since they are still not yet well developed
Excretion
Final loss of drugs from the body
Elimination
Metabolism + excretion
Types of Elimination Kinetics
Zero-order Kinetics
First-order Kinetics
Zero-order Kinetics
Constant amount of drug is eliminated per unit time, elimination is not dependent on its plasma concentration
First-order Kinetics
Constant amount in half (50%) eliminated per unit time, dependent on plasma concentration
Pharmacodynamics
Action of the Drug on the Body (Katawan), Effect of the drug on the body
Drug-receptor interaction
Affinity: ability of a Ligand to bind to receptors
Intrinsic Activity: ability of the ligand to stimulate the receptors; the ability to exert effect
Agonist
Binds to regulatory receptors and mimics regulatory effects of the endogenous signaling compounds
Types of Agonists
Full Agonist
Partial Agonist
Inverse Agonist
Full Agonist
Maximal effect (100%)
Partial Agonist
More than zero but less than one intrinsic activity, cannot produce maximal effect
Inverse Agonist
Zero or less than one intrinsic activity, produce opposite effect
Antagonist
Drugs that block or reduce the effects of an Agonist; possess 100% affinity but zero intrinsic activity
Classification of Antagonists
Functional Antagonism (Physiologic Antagonism)
Receptor Antagonism (Pharmacologic Antagonism)
Chemical Antagonism (Inactivation)
Physiological Antagonism
Binds to different receptors and produce opposite effect